Treatment outcomes and prognostic factors in 47 patients with primary anorectal malignant melanoma in the immune therapy era

Purpose Primary anorectal melanoma (ARM) accounts for approximately 1.2% of all melanomas and 16.5% of all mucosal melanomas. ARM is associated with the shortest interval to disease progression and the highest rate of metastasis; however, optimal therapeutic strategies for ARM remain controversial....

Ausführliche Beschreibung